Literature DB >> 17998178

A comparison of the penetration rate of two polyethylene acetabular liners of different levels of cross-linking. A prospective randomised trial.

P Triclot1, G Grosjean, F El Masri, J P Courpied, M Hamadouche.   

Abstract

We carried out a prospective randomised study designed to compare the penetration rate of acetabular polyethylene inserts of identical design but different levels of cross-linking at a minimum of four years follow-up. A total of 102 patients (102 hips) were randomised to receive either highly cross-linked Durasul, or contemporary Sulene polyethylene inserts at total hip replacement. A single blinded observer used the Martell system to assess penetration of the femoral head. At a mean follow-up of 4.9 years (4.2 to 6.1) the mean femoral head penetration rate was 0.025 mm/year (SD 0.128) in the Durasul group compared with 0.106 mm/year (SD 0.109) in the Sulene group (Mann-Whitney test, p = 0.0027). The mean volumetric penetration rate was 29.24 mm(3)/year (SD 44.08) in the Durasul group compared with 53.32 mm(3)/year (SD 48.68) in the Sulene group. The yearly volumetric penetration rate was 55% lower in the Durasul group (Mann-Whitney test, p = 0.0058). Longer term results are needed to investigate whether less osteolysis will occur.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17998178     DOI: 10.1302/0301-620X.89B11.19543

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  15 in total

1.  Highly crosslinked polyethylene does not reduce aseptic loosening in cemented THA 10-year findings of a randomized study.

Authors:  Per-Erik Johanson; Georgios Digas; Peter Herberts; Jonas Thanner; Johan Kärrholm
Journal:  Clin Orthop Relat Res       Date:  2012-11       Impact factor: 4.176

2.  Highly crosslinked polyethylene reduces wear in total hip arthroplasty at 5 years.

Authors:  Jonathan Mutimer; Peter A Devane; Kathryn Adams; J Geoffrey Horne
Journal:  Clin Orthop Relat Res       Date:  2010-12       Impact factor: 4.176

Review 3.  A systematic review of radiological outcomes of highly cross-linked polyethylene versus conventional polyethylene in total hip arthroplasty.

Authors:  Zongyou Mu; Jialiang Tian; Taixiang Wu; Jing Yang; Fuxing Pei
Journal:  Int Orthop       Date:  2009-01-29       Impact factor: 3.075

4.  Does vitamin E-blended polyethylene reduce wear in primary total hip arthroplasty: a blinded randomised clinical trial.

Authors:  Caroline Scemama; Philippe Anract; Valérie Dumaine; Antoine Babinet; Jean Pierre Courpied; Moussa Hamadouche
Journal:  Int Orthop       Date:  2016-11-04       Impact factor: 3.075

5.  Effect of stem alignment on long-term outcomes of total hip arthroplasty with cementless Bi-Metric femoral components.

Authors:  Takaaki Shishido; Toshiyuki Tateiwa; Yasuhito Takahashi; Toshinori Masaoka; Tsunehito Ishida; Kengo Yamamoto
Journal:  J Orthop       Date:  2018-01-16

6.  THA with highly cross-linked polyethylene in patients 50 years or younger.

Authors:  Derek S Shia; John C Clohisy; Mark F Schinsky; John M Martell; William J Maloney
Journal:  Clin Orthop Relat Res       Date:  2009-01-14       Impact factor: 4.176

7.  Polyethylene in total hip arthroplasty: half a century in the limelight.

Authors:  Eduardo García-Rey; Eduardo García-Cimbrelo
Journal:  J Orthop Traumatol       Date:  2010-05-27

8.  Dislocation after total hip arthroplasty with 28 and 32-mm femoral head.

Authors:  Einar Amlie; Øystein Høvik; Olav Reikerås
Journal:  J Orthop Traumatol       Date:  2010-05-27

9.  Femoral head size and wear of highly cross-linked polyethylene at 5 to 8 years.

Authors:  Paul F Lachiewicz; Daniel S Heckman; Elizabeth S Soileau; Jimmi Mangla; John M Martell
Journal:  Clin Orthop Relat Res       Date:  2009-08-19       Impact factor: 4.176

10.  Is there any difference in survivorship of total hip arthroplasty with different bearing surfaces? A systematic review and network meta-analysis.

Authors:  Si Yin; Dangfeng Zhang; Hui Du; Heng Du; Zhanhai Yin; Yusheng Qiu
Journal:  Int J Clin Exp Med       Date:  2015-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.